During the past decade, University of California-Davis, Department of Dermatology conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 11 clinical trials were completed, i.e. on average, 36.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of California-Davis, Department of Dermatology" #1 sponsor was "University of California, Davis" with 47 trials, followed by "Eli Lilly and Company" with 3 trials sponsored, "Cabaletta Bio" with 1 trials sponsored, "Emanual Maverakis, MD" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of California-Davis, Department of Dermatology" #1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "Incyte Corporation" with 3 trials as a collaborator and "CoolTouch, Inc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "University of California-Davis, Department of Dermatology" are "Atopic Dermatitis" (10 trials), "Melanoma" (5 trials), "Psoriasis" (4 trials), "Acne" (2 trials) and "Acne Vulgaris" (2 trials). Many other conditions were trialed in "University of California-Davis, Department of Dermatology" in a lesser frequency.

Most popular intervention types in "University of California-Davis, Department of Dermatology" are "Other" (20 trials), "Drug" (18 trials), "Device" (11 trials), "Procedure" (6 trials) and "Behavioral" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Baricitinib" (3 trials), "Patient Educational Materials" (3 trials), "Aminolevulinic Acid" (2 trials) and "Conventional in Office Care" (2 trials). Other intervention names were less common.

The vast majority of trials in "University of California-Davis, Department of Dermatology" are 53 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are 11 active trials in "University of California-Davis, Department of Dermatology". 1 are not yet recruiting, 6 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 36 completed trials in University of California-Davis, Department of Dermatology, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in University of California-Davis, Department of Dermatology, 8 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 26 trials that are defined as “Not Applicable".